Nikko Asset Management Americas, Inc. Seres Therapeutics, Inc. Transaction History

Nikko Asset Management Americas, Inc.

$10 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$2.7 - $7.62 $82,277 - $232,204	-30,473 Reduced 4.19%	696,785 $2.34 Million
Q1 2022 May 06, 2022	SELL	$6.3 - $8.84 $367,044 - $515,027	-58,261 Reduced 7.42%	727,258 $5.11 Million
Q4 2021 Feb 08, 2022	SELL	$6.02 - $11.43 $538,212 - $1.02 Million	-89,404 Reduced 10.22%	785,519 $6.57 Million
Q3 2021 Nov 09, 2021	SELL	$5.46 - $22.6 $24.1 Million - $99.6 Million	-4,405,231 Reduced 83.43%	874,923 $6.09 Million
Q2 2021 Aug 09, 2021	SELL	$18.46 - $24.36 $13.3 Million - $17.5 Million	-719,202 Reduced 11.99%	5,280,154 $119 Million

Q1 2021 May 03, 2021	BUY	$17.66 - $28.92 $3.1 Million - $5.08 Million	175,753 Added 3.02%	5,999,356 $124 Million
Q4 2020 Feb 11, 2021	BUY	$23.25 - $37.73 $6.79 Million - $11 Million	291,933 Added 5.28%	5,823,603 $143 Million
Q3 2020 Nov 02, 2020	SELL	$3.74 - $28.74 $6.99 Million - $53.7 Million	-1,868,575 Reduced 25.25%	5,531,670 $152 Million
Q2 2020 Aug 07, 2020	SELL	$3.04 - $6.2 $3.09 Million - $6.31 Million	-1,018,075 Reduced 12.09%	7,400,245 $34.8 Million
Q1 2020 Apr 30, 2020	BUY	$2.64 - $3.82 $383,056 - $554,270	145,097 Added 1.75%	8,418,320 $30.1 Million
Q4 2019 Feb 06, 2020	BUY	$2.99 - $4.42 $1.83 Million - $2.7 Million	611,260 Added 7.98%	8,273,223 $28.5 Million
Q3 2019 Oct 29, 2019	BUY	$2.29 - $4.16 $6.46 Million - $11.7 Million	2,818,889 Added 58.2%	7,661,963 $30.7 Million
Q2 2019 Jul 29, 2019	BUY	$2.28 - $7.35 $9.18 Million - $29.6 Million	4,024,575 Added 491.7%	4,843,074 $15.6 Million
Q1 2019 Apr 30, 2019	BUY	$4.83 - $7.21 $3.94 Million - $5.88 Million	815,234 Added 24968.88%	818,499 $5.62 Million
Q4 2018 Feb 08, 2019	SELL	$4.52 - $8.88 $235 - $461	-52 Reduced 1.57%	3,265 $15,000
Q3 2018 Oct 15, 2018	BUY	$7.33 - $9.23 $24,313 - $30,615	3,317 New	3,317 $25,000

Others Institutions Holding MCRB

# of Institutions

100

Shares Held

62.7M

Call Options Held

36.9K

Put Options Held

476K

Flagship Pioneering Inc. Cambridge, MA

23.1M
Shares

$16.6 Million
1.17% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$4.91 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.73M
Shares

$4.85 Million
0.0% of portfolio
Hudson Bay Capital Management LP Greenwich, CT

5.43M
Shares

$3.91 Million
0.03% of portfolio
Geode Capital Management, LLC Boston, MA

2.13M
Shares

$1.54 Million
0.0% of portfolio

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.

Account